Enhanced VEGF production and decreased immunogenicity induced by TGF-β 1 promote liver metastasis of pancreatic cancer

British Journal of Cancer

Volumn 85, Issue 4, 2001, Pages 612-617

  Teraoka, H ^a   Sawada, T ^a   Nishihara, T ^a   Yashiro, M ^a   Ohira, M ^a   Ishikawa, T ^a   Nishino, H ^a   Hirakawa, K ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Liver metastasis; Pancreatic cancer; TGF 1; VEGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LIVER METASTASIS; METASTASIS POTENTIAL; MONOCYTE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHOKINES; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035902805     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1941     Document Type: Article

References (41)

1. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells
2. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
3. + T lymphocytes
4. Defective haemetaopoiesis and vasculogenesis in transforming growth factor-β 1 knockout mice
5. Transforming growth factor-β1 (TGF-β1) and recombinant human tumor necrosis factor-α reciprocally regulate the generation of lymphokine-activated killer cell activity
6. Modulation of the organ microenvironment for treatment of cancer metastasis
7. Clinical applications of research on angiogenesis
8. Enhanced expression of transforming growth factor-β isoforms in pancreatic cancer correlates with decreased survival
9. Immnohistochemical staining for transforming growth factor-beta 1 associates with disease progression in human breast cancer
10. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
11. Extended radical resection of cancer of the pancreas with intraoperative radiotherapy
12. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line
13. Prognostic significance of angiogenesis in human pancreatic cancer
14. The enhancement of cell surface ICAM-1 and HLA Class antigens in human gastric cancer cell lines by IFN-gamma
15. Importance of E-selectin(ELAM-1) and sialyl Lewisa in the adhesion of pancreas carcinoma cells to activated endothelium
16. Vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma
17. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
18. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes
19. Loss of expression of transforming growth factor-β receptors is associated with poor prognosis in prostate cancer patients
20. Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: The importance of surface sialyl Lewisa antigen
21. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta 3 is related to disease progression
22. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
23. The transforming growth factor-beta family
24. Coexpression of VEGF and bFGF in human epidermoid lung cancer associated with increased vessel density
25. Association between tumor angiogenesis and tumor cell shedding into effluent venous blood during breast cancer surgery
26. In situ expression of transforming growth factor-beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression
27. TGF-beta 1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination
28. Enhancement of metastatic activity of colon cancer as influenced by expression of cell surface antigens
29. Transforming growth factor-beta; vasculogenesis, angiogenesis and vessel wall integrity
30. Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation
31. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
32. Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
33. E-selectin binding by pancreatic tumor cells is inhibited by cancer sera
34. The transforming growth factor-β: Recent progress and new challenges
35. Transforming growth factor-β-induced inhibition of T cell function
36. Adhesion of human colon cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewisa
37. Transforming growth factor-beta isoforms expression in pulmonary adenocarcinomas as prognostic markers: An immunohistological study of one hundred and twenty patients
38. The human gene for vascular endothelial growth factor
39. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
40. Inflammatory and immunomodulatory roles of TGF-β
41. Correlated abnormalities of transforming growth factor-β1 response and p53 expression in thyroid epithelial cell trasformation